Literature DB >> 6744784

Nicotine and carbon monoxide intake from high- and low-yield cigarettes.

N L Benowitz, P Jacob.   

Abstract

We measured daily nicotine intake in 11 habitual smokers who smoked their usual brand or commercial high-yield (Federal Trade Commission [FTC] yield 1.2 mg nicotine, 16 mg tar) or low-yield (0.4 mg nicotine, 5 mg tar) cigarettes. Daily nicotine intake was measured from metabolic clearance data in conjunction with blood and urinary concentrations of nicotine during 24-hr smoking periods. On the average, subjects consumed 35 mg nicotine while smoking their usual cigarettes and 26 mg while smoking either high- or low-yield commercial cigarettes different from their usual brand. This level of nicotine consumption from low-yield cigarettes was because smokers obtained 60% more nicotine per cigarette than predicted by FTC yield and they smoked 25% more cigarettes a day. Although there was considerable variability in nicotine intake between subjects, there was a correlation within subjects between intake while smoking their usual brand and experimental cigarettes. Nicotine intake between the two commercial high- or low-yield cigarettes also correlated (r = 0.86). These findings are consistent with a minimal level of acceptable daily intake of nicotine for individuals that is related to usual intake. We suggest that our protocol provides a better quantitative estimate of the yield of different cigarette brands and potential health hazards than those currently provided by the FTC.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744784     DOI: 10.1038/clpt.1984.173

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

1.  Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.

Authors:  David L Ashley; Richard J O'Connor; John T Bernert; Clifford H Watson; Gregory M Polzin; Ram B Jain; David Hammond; Dorothy K Hatsukami; Gary A Giovino; K Michael Cummings; Ann McNeill; Lion Shahab; Bill King; Geoffrey T Fong; Liqin Zhang; Yang Xia; Xizheng Yan; Joan M McCraw
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats.

Authors:  Matthew W Feltenstein; Shannon M Ghee; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2011-09-25       Impact factor: 4.492

3.  Chronic and acute tolerance to the heart rate effects of nicotine.

Authors:  K A Perkins; L H Epstein; R L Stiller; B L Marks; R G Jacob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

5.  Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats.

Authors:  H Foth; H Looschen; H Neurath; G F Kahl
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

6.  Early postnatal nicotine exposure disrupts the α2* nicotinic acetylcholine receptor-mediated control of oriens-lacunosum moleculare cells during adolescence in rats.

Authors:  Kang Chen; Sakura Nakauchi; Hailing Su; Saki Tanimoto; Katumi Sumikawa
Journal:  Neuropharmacology       Date:  2015-09-16       Impact factor: 5.250

7.  Impaired function of α2-containing nicotinic acetylcholine receptors on oriens-lacunosum moleculare cells causes hippocampus-dependent memory impairments.

Authors:  Elise Kleeman; Sakura Nakauchi; Hailing Su; Richard Dang; Marcelo A Wood; Katumi Sumikawa
Journal:  Neurobiol Learn Mem       Date:  2016-09-19       Impact factor: 2.877

8.  Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure.

Authors:  C J Lynch; N L Benowitz
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

9.  Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens.

Authors:  Quan Gan; Wei Lu; Jiying Xu; Xinjian Li; Maciej Goniewicz; Neal L Benowitz; Stanton A Glantz
Journal:  Tob Control       Date:  2010-05-27       Impact factor: 7.552

10.  Nicotine pharmacokinetics and its application to intake from smoking.

Authors:  C Feyerabend; R M Ings; M A Russel
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.